Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Clinical trial NCT04623931 · RECRUITING

Trial details

NCT number: NCT04623931
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Astrocytoma, IDH-Wildtype Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Diffuse Astrocytoma, IDH-Wildtype Glioblastoma Oligoastrocytoma Oligodendroglioma WHO Grade II Glioma WHO Grade III Glioma

Start date: 2020-01-30
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.